title: The HIV-1 Rev protein: a model system for coupled RNA transport and translation.
abstract: The impact of the Rev protein of the human immunodeficiency virus type 1 (HIV-1) on RNA transport, intranuclear RNA distribution, and gene expression was examined for two Rev-dependent expression systems by means of fluorescence in situ hybridization, immunofluorescence, S1 nuclease protection, and functional assays. In the pgTat expression system, which utilizes authentic HIV-1 splice signals, unspliced mRNA remained entrapped in the nucleus in the absence of Rev and was exported to the cytoplasm in its presence, consistent with published findings. In the pSVAR expression system, significant levels of mRNA were found in the nucleus and cytoplasm in both the presence and absence of Rev, but only in the presence of Rev was mRNA translated into protein. The presence of cytoplasmic untranslated mRNA in the absence of Rev was demonstrated by in situ hybridization analysis of individual cells as well as by S1 nuclease analysis of cell populations. The results indicate that Rev has the potential to affect translation as well as transport, suggesting the possibility that cellular mechanisms exist whereby the translational efficiency of an mRNA may be affected by the manner in which it is transported from the nucleus. Fluorescence hybridization also provided high-resolution visualization of the intranuclear distribution of RNAs containing the Rev response element. This demonstrated for both expression systems that mRNA was not highly localized in tracks or around the nucleolus in the presence or absence of Rev, a nucleolar protein, but was more widely distributed throughout the nucleus. In pgTat transfectants, HIV-1 RNA often became localized in 5 to 20 discrete large intranuclear clusters in the presence of Rev, the potential significance of which is discussed.
authors.affiliation: Department of Cell Biology, University of Massachusetts Medical Center, Worcester 01655.
authors.forename: J B
authors.initials: JB
authors.lastname: Lawrence
authors.forename: A W
authors.initials: AW
authors.lastname: Cochrane
authors.forename: C V
authors.initials: CV
authors.lastname: Johnson
authors.forename: A
authors.initials: A
authors.lastname: Perkins
authors.forename: C A
authors.initials: CA
authors.lastname: Rosen
mesh_terms: D001692:Biological Transport; D002874:Chromosome Mapping; D005455:Fluorescent Antibody Technique; D015967:Gene Expression Regulation, Viral; D015694:Gene Products, rev / Q000502:physiology*; D005822:Genetic Vectors; D015497:HIV-1; D066298:In Vitro Techniques; D009693:Nucleic Acid Hybridization; D014176:Protein Biosynthesis / Q000502:physiology*; D012313:RNA / Q000493:pharmacokinetics*; D012323:RNA Processing, Post-Transcriptional; D014162:Transfection; D054321:rev Gene Products, Human Immunodeficiency Virus
chemical_list: D015694:Gene Products, rev; D054321:rev Gene Products, Human Immunodeficiency Virus; D012313:RNA